3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Urinary Bladder Neoplasms
13
Colorectal Neoplasms
9
Neoplasm Metastasis
8
Peritoneal Neoplasms
6
Pancreatic Neoplasms
6
Non-Muscle Invasive Bladder Neoplasms
6
Appendiceal Neoplasms
6
Stomach Neoplasms
5
Carcinoma, Hepatocellular
5
Anus Neoplasms
5
Sarcoma
4
Rectal Neoplasms
4
Colonic Neoplasms
4
Liver Neoplasms
3
Carcinoma, Transitional Cell
3
Pseudomyxoma Peritonei
2
Mesothelioma, Malignant
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Anal Canal Carcinoma
2
Urothelial Carcinoma of the Bladder
1
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Diseases
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Pleural Neoplasms
1
Pancoast Syndrome
1
Interventions
Mitomycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Locally Advanced Anal Canal Cancer
×
Mitomycin
×
Clear all
NCT02701088
2025-09-22
CANAL-IMRT-01
Centre Francois Baclesse
Phase 2
Active not recruiting
71 enrolled